IBDEI0L8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10406,0)
 ;;=V12.51^^67^675^59
 ;;^UTILITY(U,$J,358.3,10406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10406,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,10406,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,10406,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,10407,0)
 ;;=V17.89^^67^675^18
 ;;^UTILITY(U,$J,358.3,10407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10407,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,10407,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,10407,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,10408,0)
 ;;=V12.54^^67^675^56
 ;;^UTILITY(U,$J,358.3,10408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10408,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,10408,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,10408,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,10409,0)
 ;;=V12.54^^67^675^52
 ;;^UTILITY(U,$J,358.3,10409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10409,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,10409,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,10409,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,10410,0)
 ;;=V15.88^^67^675^33
 ;;^UTILITY(U,$J,358.3,10410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10410,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,10410,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,10410,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,10411,0)
 ;;=V13.59^^67^675^42
 ;;^UTILITY(U,$J,358.3,10411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10411,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,10411,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,10411,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,10412,0)
 ;;=V15.52^^67^675^55
 ;;^UTILITY(U,$J,358.3,10412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10412,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,10412,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,10412,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,10413,0)
 ;;=V12.04^^67^675^38
 ;;^UTILITY(U,$J,358.3,10413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10413,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,10413,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,10413,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,10414,0)
 ;;=V13.51^^67^675^23
 ;;^UTILITY(U,$J,358.3,10414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10414,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,10414,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,10414,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,10415,0)
 ;;=V15.51^^67^675^58
 ;;^UTILITY(U,$J,358.3,10415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10415,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,10415,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,10415,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,10416,0)
 ;;=V62.22^^67^675^49
 ;;^UTILITY(U,$J,358.3,10416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10416,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,10416,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,10416,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,10417,0)
 ;;=V70.0^^67^676^1
 ;;^UTILITY(U,$J,358.3,10417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10417,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,10417,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,10417,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,10418,0)
 ;;=V77.91^^67^676^2
 ;;^UTILITY(U,$J,358.3,10418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10418,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,10418,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,10418,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,10419,0)
 ;;=V76.44^^67^676^3
 ;;^UTILITY(U,$J,358.3,10419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10419,1,4,0)
 ;;=4^V76.44
